内科学
旁侵犯
医学
幽门螺杆菌
癌症
淋巴血管侵犯
胃肠病学
单变量分析
阶段(地层学)
多元分析
肿瘤科
疾病
人口
转移
生物
古生物学
环境卫生
作者
Ali Kemal Kayapınar,D Solakoglu,Koray Baş,Erkan Oymacı,Banu İşbilen,B Calik,Gülden Dınız,Gamze Akbulut
出处
期刊:Acta gastro-enterologica belgica
[Acta Gastro Enterologica Belgica]
日期:2022-03-01
卷期号:85 (1): 35-45
被引量:1
摘要
Background and study aims: The prognostic value of H. pylori, which infects more than half of the human population living in the world and plays a role in gastric cancer pathogenesis, is controversial. Our aim is to investigate the relationship between H. pylori and prognostic factors in gastric cancer. Patients and methods: The data of 110 patients (38 females and 72 males) that underwent surgeries due to gastric cancer between 2014 and 2017 were retrospectively analyzed. The relationships between survival (disease-free and overall) and factors such as p53, HER2/neu, Ki-67, neutrophil and platelet lymphocyte ratio (NLR / PLR), histopathological and demographic characteristics were examined. In addition, the results of H. pylori positive and negative groups were compared. Results: Sixty-one (55%) patients were H. pylori negative and 49 (45%) were positive. In multivariate analysis, TNM stage, lymph node capsule invasion and NLR were determined as independent prognostic factors in both disease-free and overall survival. Age>62 and PLR>14.3 were determined as independent predictive factors of poor prognosis in overall survival. In univariate analysis, tumor diameter of >4.3 cm, lymphovascular and perineural invasion, and diffuse p53 expression were determined as predictive factors of poor prognosis in disease-free and overall survival. The effectiveness of these markers in prognosis was not different between H. pylori negative and positive groups. Conclusion: While age, tumor diameter, TNM stage, lymph node capsule invasion, perineural and lymphovascular invasion, diffuse p53, PLR, and NLR were determined as prognostic factors in gastric cancer, these factors were not affected by the presence of H. pylori.
科研通智能强力驱动
Strongly Powered by AbleSci AI